Why Alzheimer’s Meds Rarely Help

    The nonprofit Alzheimer’s Association projects that the number of people living with Alzheimer’s disease will soar, from 5 million to 13.8 million by 2050, unless scientists develop new ways to stop the disease. Current medications do not treat Alzheimer’s or stop it from progressing; they only temporarily lessen symptoms, such as memory loss and confusion.

    Current Alzheimer’s drugs aim to reduce the amyloid plaques — sticky deposits that build up in the brain — that are a visual trademark of the disease. These plaques are made of long fibers of a protein called amyloid beta, or Aß. Recent studies, however, suggest that the real culprit behind Alzheimer’s may be small Aß clumps, called oligomers, that appear in the brain years before plaques develop.

    In unraveling the molecular structure of oligomers, UCLA scientists, led by Zhefeng Guo, PhD, assistant professor of neurology and a member of UCLA’s Brain Research Institute and Molecular Biology Institute, discovered that Aß has a vastly different organization in oligomers than in amyloid plaques. Their finding could shed light on why Alzheimer’s drugs designed to seek out amyloid plaques have no effect on oligomers; the study suggests that the drugs failed in clinical trials because they zero in on plaques and do not work on oligomers. Future studies on oligomers will help speed the development of new drugs specifically aiming at Aß oligomers, the researchers say.

    “Teasing Out the Structural Details of an Oligomer Involved in Alzheimer Disease: Structural Insights into Aß42 Oligomers Using Site-directed Spin Labeling,” Journal of Biological Chemistry, June 28, 2013

     

    Photo by dolgachov/Thinkstock
    While we routinely make sacrifices for the people we feel closest to — our spouses, children and...
    illustration by Carl wiens
    Lessons learned from early organ recipients continue to hearten the future of transplant medicine....
    Could our reaction to an image of an overweight or obese person affect how we perceive odor? A trio...
    Molecular inhibitor represents new treatment target for drugs to halt atherosclerosis Working with...
    Gene Variation Affects Brain Cell Development Johns Hopkins researchers have begun to connect the...
    Molecular “Eat Now” Sign Makes Cells Devour Dying Neighbors A team of researchers has devised a Pac...
    Star-shaped brain cells may help control brain’s focus A new study from The Johns Hopkins...
    Discoveries hail from cataloging human proteins Striving for the protein equivalent of the Human...
    Compounds in saliva may fend off chemicals in tea and coffee A compound in saliva, along with...
    Scientists discover how tumor cells divide when oxygen-starved Most cells do not divide unless...